- Home
- KROS vs LEGH Comparison
KROS vs LEGH Comparison
Compare KROS & LEGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- LEGH
- Stock Information
- Founded
- KROS 2015
- LEGH 2005
- Country
- KROS United States
- LEGH United States
- Employees
- KROS N/A
- LEGH N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- LEGH Homebuilding
- Sector
- KROS Health Care
- LEGH Consumer Discretionary
- Exchange
- KROS Nasdaq
- LEGH Nasdaq
- Market Cap
- KROS 565.0M
- LEGH 646.4M
- IPO Year
- KROS 2020
- LEGH 2018
- Fundamental
- Price
- KROS $15.80
- LEGH $27.67
- Analyst Decision
- KROS Buy
- LEGH Strong Buy
- Analyst Count
- KROS 14
- LEGH 1
- Target Price
- KROS $20.56
- LEGH $29.00
- AVG Volume (30 Days)
- KROS 417.9K
- LEGH 73.8K
- Earning Date
- KROS 11-05-2025
- LEGH 11-11-2025
- Dividend Yield
- KROS N/A
- LEGH N/A
- EPS Growth
- KROS N/A
- LEGH 2.38
- EPS
- KROS 0.47
- LEGH 2.23
- Revenue
- KROS $232,844,000.00
- LEGH $184,284,000.00
- Revenue This Year
- KROS $5,579.44
- LEGH $0.57
- Revenue Next Year
- KROS N/A
- LEGH $8.92
- P/E Ratio
- KROS $34.08
- LEGH $12.30
- Revenue Growth
- KROS 85820.30
- LEGH 8.79
- 52 Week Low
- KROS $9.12
- LEGH $21.58
- 52 Week High
- KROS $72.37
- LEGH $29.45
- Technical
- Relative Strength Index (RSI)
- KROS 60.69
- LEGH 60.04
- Support Level
- KROS $15.34
- LEGH $26.96
- Resistance Level
- KROS $15.85
- LEGH $27.75
- Average True Range (ATR)
- KROS 0.48
- LEGH 0.73
- MACD
- KROS -0.01
- LEGH -0.20
- Stochastic Oscillator
- KROS 78.71
- LEGH 35.04
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About LEGH Legacy Housing Corporation (TX)
Legacy Housing Corp builds, sell, and finance manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores and also sold directly to manufactured home communities. The company also provides financing options to its customers to facilitate the sale of homes.